Đang chuẩn bị liên kết để tải về tài liệu:
A germline mutation in the BRCA1 3’UTR predicts Stage IV breast cancer

Mạnh Nghiêm 68 11 pdf

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ Tải xuống

A germline, variant in the BRCA1 3’UTR (rs8176318) was previously shown to predict breast and ovarian cancer risk in women from high-risk families, as well as increased risk of triple negative breast cancer. Here, we tested the hypothesis that this variant predicts tumor biology, like other 3’UTR mutations in cancer. |

TÀI LIỆU LIÊN QUAN

BRCA1 germline mutation and glioblastoma development: Report of cases

Pedigree investigation, clinical characteristics, and prognosis analysis of haematological disease patients with germline TET2 mutation

Germline and somatic mutations in patients with multiple primary melanomas: A next generation sequencing study

A germline mutation in Rab43 gene identified from a cancer family predisposes to a hereditary liver-colon cancer syndrome

Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancer

A germline mutation of CDKN2A and a novel RPLP1-C19MC fusion detected in a rare melanotic neuroectodermal tumor of infancy: A case report

The mtDNA mutation spectrum in the PolG mutator mouse reveals germline and somatic selection

Germline contamination and leakage in whole genome somatic single nucleotide variant detection

Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: A case report and literature review

A novel Bruton’s tyrosine kinase gene (BTK) missense mutation in a Chinese family with X-linked agammaglobulinemia

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.